Literature DB >> 28868346

Heterogeneity among Lgr5-positive colon stem cells.

Daisuke Shiokawa1, Koji Okamoto1.   

Abstract

Leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5) is considered a representative marker of intestinal stem cells from both non-tumor and tumor tissues. However, it remains unclear whether all or only a fraction of Lgr5-positive cells behave as stem cells. Recently, we reported that Lgr5-positive cells from non-tumor and tumor tissues can be classified into overlapping yet distinct groups and that the tumor-specific groups are associated with tumorigenic capability, suggesting that these cells could represent targets for therapeutic intervention.

Entities:  

Keywords:  Cancer stem cells; Lgr5; colon carcinogenesis; single-cell analyses

Year:  2017        PMID: 28868346      PMCID: PMC5540210          DOI: 10.1080/23723556.2017.1335271

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN: 2372-3556


  10 in total

Review 1.  Microenvironmental regulation of stem cells in intestinal homeostasis and cancer.

Authors:  Jan Paul Medema; Louis Vermeulen
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

2.  The Induction of Selected Wnt Target Genes by Tcf1 Mediates Generation of Tumorigenic Colon Stem Cells.

Authors:  Daisuke Shiokawa; Ai Sato; Hirokazu Ohata; Michihiro Mutoh; Shigeki Sekine; Mamoru Kato; Tatsuhiro Shibata; Hitoshi Nakagama; Koji Okamoto
Journal:  Cell Rep       Date:  2017-05-02       Impact factor: 9.423

Review 3.  Regulation and plasticity of intestinal stem cells during homeostasis and regeneration.

Authors:  Joep Beumer; Hans Clevers
Journal:  Development       Date:  2016-10-15       Impact factor: 6.868

Review 4.  Stem cells marked by the R-spondin receptor LGR5.

Authors:  Bon-Kyoung Koo; Hans Clevers
Journal:  Gastroenterology       Date:  2014-05-21       Impact factor: 22.682

Review 5.  Evolution of the cancer stem cell model.

Authors:  Antonija Kreso; John E Dick
Journal:  Cell Stem Cell       Date:  2014-03-06       Impact factor: 24.633

6.  A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer.

Authors:  Felipe de Sousa e Melo; Antonina V Kurtova; Jonathan M Harnoss; Noelyn Kljavin; Joerg D Hoeck; Jeffrey Hung; Jeffrey Eastham Anderson; Elaine E Storm; Zora Modrusan; Hartmut Koeppen; Gerrit J P Dijkgraaf; Robert Piskol; Frederic J de Sauvage
Journal:  Nature       Date:  2017-03-29       Impact factor: 49.962

7.  Visualization and targeting of LGR5+ human colon cancer stem cells.

Authors:  Mariko Shimokawa; Yuki Ohta; Shingo Nishikori; Mami Matano; Ai Takano; Masayuki Fujii; Shoichi Date; Shinya Sugimoto; Takanori Kanai; Toshiro Sato
Journal:  Nature       Date:  2017-03-29       Impact factor: 49.962

8.  Crypt stem cells as the cells-of-origin of intestinal cancer.

Authors:  Nick Barker; Rachel A Ridgway; Johan H van Es; Marc van de Wetering; Harry Begthel; Maaike van den Born; Esther Danenberg; Alan R Clarke; Owen J Sansom; Hans Clevers
Journal:  Nature       Date:  2008-12-17       Impact factor: 49.962

9.  Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.

Authors:  Arnout G Schepers; Hugo J Snippert; Daniel E Stange; Maaike van den Born; Johan H van Es; Marc van de Wetering; Hans Clevers
Journal:  Science       Date:  2012-08-01       Impact factor: 47.728

10.  Single-cell dissection of transcriptional heterogeneity in human colon tumors.

Authors:  Piero Dalerba; Tomer Kalisky; Debashis Sahoo; Pradeep S Rajendran; Michael E Rothenberg; Anne A Leyrat; Sopheak Sim; Jennifer Okamoto; Darius M Johnston; Dalong Qian; Maider Zabala; Janet Bueno; Norma F Neff; Jianbin Wang; Andrew A Shelton; Brendan Visser; Shigeo Hisamori; Yohei Shimono; Marc van de Wetering; Hans Clevers; Michael F Clarke; Stephen R Quake
Journal:  Nat Biotechnol       Date:  2011-11-13       Impact factor: 54.908

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.